AstraZeneca's 'Storm Chaser' COVID trial misses goal but offers some hope

Drug fails to stop people developing symptomatic COVID, but may help those who have not yet come into contact with virus

India Capital Growth Fund Ltd (IGC.L)

LSE - LSE Delayed price. Currency in GBp

Add to watchlist

108.93+1.93 (+1.80%)

As of 2:29PM BST. Market open.

Major holders

Invalid Date data is not available